Journal Information

Statistics

Follow this link to access the full text of the article

Case Report
Case of large lentigo maligna melanoma of the scalp treated with 5% and 3.75% Imiquimod
Miriam Rovesti
Corresponding author
miriam.rovesti@gmail.com

Corresponding author.
, Alfredo Zucchi, Claudio Feliciani, Francesca Satolli
Department of Dermatology, University of Parma, Parma, Italy
Read
4633
Times
was read the article
2089
Total PDF
2544
Total HTML
Share statistics
Article information
ISSN: 03650596
Original language: English
The statistics are updated each day
Year/Month Html Pdf Total
2024 April 153 76 229
2024 March 103 73 176
2024 February 96 98 194
2024 January 79 47 126
2023 December 65 57 122
2023 November 64 89 153
2023 October 61 82 143
2023 September 74 70 144
2023 August 50 31 81
2023 July 75 44 119
2023 June 61 35 96
2023 May 59 19 78
2023 April 65 20 85
2023 March 80 52 132
2023 February 67 32 99
2023 January 65 48 113
2022 December 66 36 102
2022 November 86 72 158
2022 October 107 50 157
2022 September 82 76 158
2022 August 65 51 116
2022 July 57 65 122
2022 June 95 60 155
2022 May 74 52 126
2022 April 84 64 148
2022 March 65 69 134
2022 February 44 38 82
2022 January 78 96 174
2021 December 65 79 144
2021 November 75 66 141
2021 October 108 109 217
2021 September 126 118 244
2021 August 39 97 136
2021 July 11 18 29
Show all

Follow this link to access the full text of the article

Idiomas
Anais Brasileiros de Dermatologia
en pt
Cookies policy Política de cookies
To improve our services and products, we use "cookies" (own or third parties authorized) to show advertising related to client preferences through the analyses of navigation customer behavior. Continuing navigation will be considered as acceptance of this use. You can change the settings or obtain more information by clicking here. Utilizamos cookies próprios e de terceiros para melhorar nossos serviços e mostrar publicidade relacionada às suas preferências, analisando seus hábitos de navegação. Se continuar a navegar, consideramos que aceita o seu uso. Você pode alterar a configuração ou obter mais informações aqui.